Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000306
Chunk: 105

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 105
---
idiaries, taken as a whole, (C) any
change arising in connection with pandemics, earthquakes, hostilities, acts of war, sabotage or terrorism or military actions or any escalation
or material worsening of any such hostilities, acts of war, sabotage or terrorism or military actions, (D) any action taken, or omitted
to be taken, by the Holder, its affiliates or its or their respective successors and assigns with respect to the transactions contemplated
by this Note, (E) the effect of any change in applicable laws or accounting rules that does not have a disproportionate effect on the
Company and its Subsidiaries, taken as a whole, or (F) any change resulting from compliance with terms of this Note or the consummation
of the transactions contemplated by this Note, or (iii) the Company’s ability to perform in any material respect on a timely basis
its obligations under this Note to be performed as of the date of determination.

(f) “”
means any other promissory notes issued by the Company to the Holder.

(g) “”
shall mean the Company’s (i) Annual Report on Form 20-F and(ii) any financial report to be filed on Form 6-K..

(h) “”
means a corporation, an association, a partnership, organization, a business, an individual, a government or political subdivision thereof
or a governmental agency.

(i) “”
shall mean any trading tier of The Nasdaq Stock Market LLC; provided however, that in the event the ADSs are ever listed or traded on
the New York Stock Exchange, or the NYSE American, then the “Principal Market” shall mean such other market or exchange on
which the ADSs are then listed or traded to the extent such other market or exchange is the principal trading market or exchange for the
ADSs.

(j) “”
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

(k) “”
means, with respect to any Person, any corporation, association, partnership or other business entity of which more than 50% of the total
voting power of shares of capital stock or other interests (including partnership interests) entitled (without regard to the occurrence
of any contingency) to vote in the election of directors, managers, general partners or trustees thereof is at the time owned or controlled,
directly or indirectly, by (i) such Person; (ii) such Person and one or more Subsidiaries